Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀå : ¾àǰ Ŭ·¡½ºº°, À¯Çüº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°
Antiviral Drugs Market, By Drug Class, By Type, By Application, By Distribution Channel, By Geography
»óǰÄÚµå : 1672820
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 10,128,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀåÀº 2025³â¿¡ 670¾ï 4,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 963¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö CAGR 5.3%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 670¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ CAGR(2025-2032³â) 5.30% ±Ý¾× ¿¹Ãø(2032³â) 963¾ï ´Þ·¯
±×¸². Ç×¹ÙÀÌ·¯½ºÁ¦ Áö¿ªº° ½ÃÀå Á¡À¯À²(%)(2025³â)
Antiviral Drugs Market-IMG1

¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀåÀº Áö³­ ¸î ³âµ¿¾È ²ÙÁØÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. Ç×¹ÙÀÌ·¯½ºÁ¦´Â Ç×¹ÙÀÌ·¯½º¾à ¶Ç´Â Ç×°¨¿°Á¦·Îµµ ¾Ë·ÁÁ® ÀÖÀ¸¸ç, ¹ÙÀÌ·¯½º¿¡ ÀÇÇÑ °¨¿° Ä¡·á¿¡ ƯȭµÇ¾î »ç¿ëµÇ´Â ¾àÁ¦ À¯Çüº°ÀÔ´Ï´Ù. Ç×¹ÙÀÌ·¯½ºÁ¦´Â ¹ÙÀÌ·¯½ºÀÇ »ý»êÀ» ÀúÇØÇϰųª, ü³»¿¡¼­ÀÇ ¹ÙÀÌ·¯½ºÀÇ È®»êÀ» ¸·´Â °ÍÀ¸·Î È¿°ú¸¦ ¹ßÈÖÇÕ´Ï´Ù. HIV/AIDS, °£¿°, ÀÎÇ÷翣ÀÚ µî ¹ÙÀÌ·¯½º¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2020³â¿¡´Â ¼¼°è¿¡¼­ ¾à 3,670¸¸ ¸íÀÌ HIV °¨¿°ÀÚ°¡ µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀåÀÇ ¼ºÀåÀº ¹ÙÀÌ·¯½º °¨¿°°ú À¯ÇàÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °ßÀεǰí ÀÖ½À´Ï´Ù. COVID-19 ÆÒµ¥¹ÍÀÇ ÃâÇöÀº Ä¡·á¸¦ À§ÇÑ Ç×¹ÙÀÌ·¯½ºÁ¦ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ È£ÀÇÀûÀÎ Áö¿ø°ú ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ ÁöÃâ Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª â¾à°ú °³¹ß°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ¾ö°ÝÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀº ½ÃÀå È®´ë¸¦ ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù. Ç÷¯½º ¸é¿¡¼­´Â ½Å±Ô Ç×¹ÙÀÌ·¯½º Ä¡·á °³¹ßÀ» À§ÇÑ ¿¬±¸ °³¹ßÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ÇâÈÄ ¼ö³â°£Àº Âü°¡ ±â¾÷¿¡ À־ À¯¸®ÇÑ ±âȸ°¡ »ý±æ °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦ ¹× µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀå : COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦6Àå ¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀå : À¯Çüº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦7Àå ¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀå : ¿ëµµº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦8Àå ¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀå : À¯Åë ä³Îº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦9Àå ¼¼°èÀÇ Ç×¹ÙÀÌ·¯½ºÁ¦ ½ÃÀå : Áö¿ªº°(2020-2032³â)(10¾ï ´Þ·¯)

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ºÐ¼®°¡ Ãßõ

Á¦12Àå Âü°í¹®Çå ¹× Á¶»ç¹æ¹ý

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Antiviral Drugs Market is estimated to be valued at USD 67.04 Bn in 2025 and is expected to reach USD 96.30 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 67.04 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.30% 2032 Value Projection: USD 96.30 Bn
Figure. Antiviral Drugs Market Share (%), By Region 2025
Antiviral Drugs Market - IMG1

The global antiviral drugs market has been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agents or anti-infective medications, are a class of medication used specifically for treating infections caused by viruses. They work by inhibiting the production of viruses or preventing their spread in the body. Rising prevalence of viral diseases such as HIV/AIDS, hepatitis, influenza and others have been fueling demand for antiviral medications globally. According to the World Health Organization (WHO), around 36.7 million people were living with HIV worldwide in 2020.

Market Dynamics:

The global antiviral drugs market growth is driven by the growing incidence of viral infections and pandemics. The emergence of COVID-19 pandemic has further augmented the demand for antiviral drugs for treatment. Favorable government support and rising expenditure on healthcare facilities are also propelling the market growth. However, high costs associated with drug discovery and development as well as stringent regulatory approvals are restraining the market expansion. On the positive side, increasing R&D for developing novel antiviral therapeutics is expected to create lucrative opportunities for players in the coming years.

Key Features of the Study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Antiviral Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

5. Global Antiviral Drugs Market, By Drug Class, 2020 - 2032, (USD Bn)

6. Global Antiviral Drugs Market, By Type, 2020 - 2032, (USD Bn)

7. Global Antiviral Drugs Market, By Application, 2020 - 2032, (USD Bn)

8. Global Antiviral Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

9. Global Antiviral Drugs Market, By Region, 2020 - 2032, (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â